Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D2 receptor gene

被引:0
|
作者
Kishida, I
Kawanishi, C
Furuno, T
Matsumura, TK
Hasegawa, H
Kato, D
Sugiyama, N
Suzuki, K
Yamada, Y
Kosaka, K
机构
[1] Yokohama City Univ, Sch Med, Dept Psychiat, Yokohama, Kanagawa 232, Japan
[2] Hiratsuka Hosp, Kanagawa, Japan
[3] Fujisawa Hosp, Kanagawa, Japan
[4] Takaoka Hosp, Shizuoka, Japan
[5] Numazu Cent Hosp, Shizuoka, Japan
关键词
D O I
10.1097/00004850-200305000-00035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:186 / 186
页数:1
相关论文
共 50 条
  • [1] Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D2 receptor gene
    I Kishida
    C Kawanishi
    T Furuno
    D Kato
    T Ishigami
    K Kosaka
    Molecular Psychiatry, 2004, 9 : 293 - 298
  • [2] Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D2 receptor gene
    Kishida, I
    Kawanishi, C
    Furuno, T
    Kato, D
    Ishigami, T
    Kosaka, K
    MOLECULAR PSYCHIATRY, 2004, 9 (03) : 293 - 298
  • [3] Association between neuroleptic malignant syndrome and polymorphisms of the dopamine D2 receptor gene
    Kishida, I
    Kawanishi, C
    Furuno, T
    Kato, D
    Kanai, A
    Yamada, T
    Yamada, Y
    Hirayasu, Y
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (03) : 175 - 176
  • [4] The relationship between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D2 receptor gene
    Sugai, Takuro
    Suzuki, Yutaro
    Sawamura, Kazushi
    Fukui, Naoki
    Muratake, Tatuyuki
    Kawasima, Yosiaki
    Taturo, Takasu
    Someya, Toshiyuki
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (04) : A4 - A4
  • [5] Investigating the association between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D2 and D3 receptor gene
    Kishida, I
    Kawanishi, C
    Furuno, T
    Kato, D
    Hirayasu, Y
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S244 - S244
  • [6] Lack of association in Japanese patients between neuroleptic malignant syndrome and the Taql A polymorphism of the dopamine D2 receptor gene
    Kishida, I
    Kawanishi, C
    Furuno, T
    Matsumura, T
    Hasegawa, H
    Sugiyama, N
    Suzuki, K
    Yamada, Y
    Kosaka, K
    PSYCHIATRIC GENETICS, 2003, 13 (01) : 55 - 57
  • [7] Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome
    Mihara, K
    Kondo, T
    Suzuki, A
    Yasui-Furukori, N
    Ono, S
    Sano, A
    Koshiro, K
    Otani, K
    Kaneko, S
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2003, 117B (01): : 57 - 60
  • [8] Association of the TaqI a polymorphism of the dopamine D2 receptor gene with predisposition to neuroleptic malignant syndrome
    Suzuki, A
    Kondo, T
    Otani, K
    Mihara, K
    Yasui-Furukori, N
    Sano, A
    Koshiro, K
    Kaneko, S
    AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (10): : 1714 - 1716
  • [9] D2 dopamine receptor polymorphisms in Italian patients experiencing neuroleptic malignant syndrome: a case series
    Tuccori, M.
    Lastella, M.
    Di Paolo, A.
    Montagnani, S.
    Salvetti, A.
    Litta, A.
    Casamassima, F.
    Lattanzi, L.
    Blandizi, C.
    Del Tacca, M.
    DRUG SAFETY, 2006, 29 (10) : 936 - 936
  • [10] Association between three functional polymorphisms of the dopamine D2 receptor gene and polydipsia in schizophrenia
    Matsumoto, C
    Shinkai, T
    De Luca, V
    Hwang, R
    Hori, H
    Lanktree, M
    Ohmori, O
    Kennedy, JL
    Nakamura, J
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2005, 8 (02): : 245 - 253